All-in

The All-In Podcast discusses Anthropic's significant enterprise growth driven by coding capabilities compared to OpenAI's declining consumer market share. The hosts also debate the economic impact of massive tort litigation against social media companies and the strategic importance of the newly appointed PCAST members in the context of the global scientific race with China.

The All-In Podcast explores the intense competition in the AI sector, contrasting Anthropic's enterprise-focused "generational run" with OpenAI's declining consumer market share. The discussion also covers the legal and societal implications of social media addiction, the potential for AI to erode traditional brand moats, and the strategic importance of the US-China scientific race following new appointments to PCAST.

The All-In Podcast features Travis Kalanick and Michael Dell discussing the convergence of AI and physical automation, the economic migration from California to Texas, and the massive growth in AI infrastructure. A significant portion of the episode focuses on the "Invest America Act" and Michael Dell’s $6.25 billion philanthropic pledge to provide funds for children in low-income communities.

This episode of the All-In Podcast features a deep dive with Travis Kalanick and Michael Dell, focusing on the transition from digital AI to "physical AI" and the economic importance of the Texas tech boom. The conversation covers Kalanick's new company, Atoms, which aims to automate physical industries like food and mining, and Michael Dell's insights into the massive expansion of AI data center infrastructure.

This special solo episode explores the multifaceted fallout of the Jeffrey Epstein investigations through three distinct lenses: the systemic corruption of global elites, the skepticism of media-driven "mythology," and the investigation of tech connections. The discussion debates the validity of mass victim claims, the massive financial incentives driving litigation, and evidence of extensive, undisclosed relationships between tech leaders like Reid Hoffman and Epstein.

This special episode of the All-In Podcast features a debate regarding the legitimacy of the "Epstein Files," exploring whether the scandal reveals a corrupt "Epstein class" operating above the law or a media-driven "mythology" fueled by legal and financial incentives. The discussion examines recent evidence regarding high-profile figures like Reid Hoffman and questions the veracity of widespread claims involving global intelligence networks and massive sex-trafficking rings.

The All-In podcast discusses the emergence of AI agents as a productivity driver, the potential security risks of cloud-based AI, and the growing "debt death spiral" in the United States. The speakers also debate the economic impacts of immigration enforcement and explore the future of automotive design and autonomy.

The All-In podcast discusses the transformative impact of AI agents on productivity, the regulatory complexities of prediction markets, and the looming threat of a US "debt death spiral." The hosts also debate the economic implications of immigration and minimum wage policies, and wrap up with a look at Ferrari's upcoming electric vehicle.

Satya Nadella discusses the transition of AI from simple chatbots to autonomous agents that allow for "macro-delegation and micro-steering" of complex tasks. He outlines Microsoft's strategy to build "token factories" through Azure and an "app server" business, while arguing that AI will transform specialized roles into "full stack builders" and accelerate the productivity of new workers.

Satya Nadella discusses the profound structural shift in knowledge work caused by the transition from simple AI assistants to autonomous agents. He argues that the future of the industry lies in the "diffusion" of technology and the creation of massive ecosystems through "token factories" and "app servers."

FDA Commissioner Marty Makary discusses his mission to modernize the FDA by accelerating drug approval timelines, reducing regulatory red tape, and shifting focus toward the root causes of disease like nutrition and the microbiome. He emphasizes the need for the US to remain competitive with China in biotechnology by adopting more efficient, data-driven, and transparent regulatory processes.

FDA Commissioner Marty Makary discusses his mission to modernize the FDA by reducing regulatory red tape, accelerating drug approval timelines, and rebuilding public trust through scientific transparency. He emphasizes the need for the US to outpace China in biotechnology and advocates for a "common sense" approach to nutrition and medicine.

This episode of the All-In Podcast, recorded at CES 2026, explores the unprecedented scale of the AI revolution and its ability to dwarf previous technological shifts like the internet and mobile. The discussion highlights how AI is fundamentally reshaping corporate strategy, venture capital, the global workforce, and the future of physical automation like robotics and self-driving cars.